Company Filing History:
5 out of 74 
1 out of 4 
1 out of 1 Years Active: 2008-2015
Title: **Shu-Ping Chen: Innovator in Pharmaceutical Chemistry**
Introduction
Shu-Ping Chen is a prominent inventor based in Kaohsiung, Taiwan, renowned for his contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of eight patents, he specializes in the development of novel pharmaceutical compounds that enhance therapeutic efficacy.
Latest Patents
Among his latest patents, Shu-Ping Chen has developed innovative crystalline and non-crystalline forms of SGLT2 inhibitors. These inventions focus on providing amorphous forms and crystalline complexes of SGLT2 inhibitors, particularly in a pharmaceutically acceptable form. Notably, the crystalline forms of the SGLT2 inhibitor canagliflozin are designated as Forms CS1, CS2, CS3, CS4, and CS5. Additionally, he has patented new anhydrous crystalline forms of docetaxel along with a process for their preparation, which includes making anhydrous docetaxel and docetaxel trihydrate.
Career Highlights
Shu-Ping Chen has worked with several reputable companies in the pharmaceutical industry, most notably Scinopharm Taiwan, Ltd. and Scinopharm Singapore Pte Ltd. His innovative work in these organizations has significantly contributed to advancements in the development of pharmaceutical products.
Collaborations
Throughout his career, Shu-Ping Chen has collaborated with notable professionals such as Meng-Fen Ho and Piin-Jye Harn. These partnerships have fostered a creative and dynamic research environment, facilitating the exchange of ideas and expertise that enhance the quality of his inventions.
Conclusion
Shu-Ping Chen exemplifies the innovative spirit in the pharmaceutical field, with a focus on developing effective treatment options through his unique inventions. His contributions to the industry will undoubtedly have a lasting impact on therapeutic practices and patient care.